Funding is not really the problem except in a general sense that govt funding is down. Private donations have been huge for Alzheimer's for a decade and pharmaceutical companies are now where the promising research is ongoing-hence a number of researchers are leaving academics and heading up projects for pharmaceutical companies. It is predicted that within the next ten years a number of new drugs, amyloid vaccine, tau and apolipoprotein E alleles altering strategies will be ready for the public as many are already in clinical trials. While the embryonic stem cell strategy seemed promising it is now on a back burner. Stem cell do have a unique ability to find damaged areas and this ability may be used more as a means to target some of the new drugs and agents to damaged areas of the brain. There are also a lot of preventive health habits one can adopt, but generally the public doesn't respond well just like type II diabetes and heart disease preventive measures are often ignored. Combinations of attacking amyloid, tau, and suppressing mutant apoE alleles will probably be clinically applied within the decade.







